Black Diamond Therapeutics (BDTX) Net Cash Flow Growth (1y) (2020 - 2026)
Black Diamond Therapeutics (BDTX) Net Cash Flow Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 301.06% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - | -85.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -85.35% |
| Dec 31, 2025 | -175.91% |
| Sep 30, 2025 | 109.32% |
| Jun 30, 2025 | -1,025.70% |
| Mar 31, 2025 | 301.24% |
| Dec 31, 2024 | 841.87% |
| Sep 30, 2024 | -159.83% |
| Jun 30, 2024 | 163.34% |
| Mar 31, 2024 | -738.27% |
| Dec 31, 2023 | 91.08% |
| Sep 30, 2023 | 918.00% |
| Jun 30, 2023 | 61.23% |
| Mar 31, 2023 | 141.18% |
| Dec 31, 2022 | -202.34% |
| Sep 30, 2022 | -120.66% |
| Jun 30, 2022 | -92.50% |
| Mar 31, 2022 | 42.84% |
| Dec 31, 2021 | 188.90% |
| Sep 30, 2021 | 240.19% |
| Jun 30, 2021 | 107.92% |